<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
#f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url("0.ttf"); }
#f1 { font-family:ff0,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff1; src: url("1.ttf"); }
#f2 { font-family:ff1,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff2; src: url("2.ttf"); }
#f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff3; src: url("3.ttf"); }
#f4 { font-family:ff3,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff4; src: url("4.ttf"); }
#f5 { font-family:ff4,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff5; src: url("5.ttf"); }
#f6 { font-family:ff5,sans-serif; font-weight:bold; font-style:normal; }
</style>
</head>
<body>
<img id="background" style="position:absolute; left:0px; top:0px;" width="595" height="842" src="page1.png">
<div class="txt" style="position:absolute; left:412px; top:30px;"><span id="f3" style="font-size:18px;vertical-align:baseline;color:rgba(0,0,0,1);">실적 </span><span id="f6" style="font-size:14px;vertical-align:baseline;color:rgba(0,0,0,1);">Review</span></div>
<div class="txt" style="position:absolute; left:412px; top:60px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">2018. 10. 24</span></div>
<div class="txt" style="position:absolute; left:38px; top:136px;"><span id="f3" style="font-size:27px;vertical-align:baseline;color:rgba(0,0,0,1);">삼성바이오로직스</span><span id="f3" style="font-size:21px;vertical-align:baseline;color:rgba(0,0,0,1);">(207940)</span></div>
<div class="txt" style="position:absolute; left:426px; top:135px;"><span id="f2" style="font-size:9px;vertical-align:baseline;color:rgba(255,255,255,1);">하 회</span></div>
<div class="txt" style="position:absolute; left:474px; top:135px;"><span id="f2" style="font-size:9px;vertical-align:baseline;color:rgba(255,255,255,1);">부 합</span></div>
<div class="txt" style="position:absolute; left:412px; top:153px;"><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">영업이익의 컨센서스 대비를 의미</span></div>
<div class="txt" style="position:absolute; left:524px; top:135px;"><span id="f2" style="font-size:9px;vertical-align:baseline;color:rgba(255,255,255,1);">상 회</span></div>
<div class="txt" style="position:absolute; left:38px; top:201px;"><span id="f3" style="font-size:15px;vertical-align:baseline;color:rgba(0,0,0,1);">실적보다 더 중요한건 증선위라네</span></div>
<div class="txt" style="position:absolute; left:49px; top:245px;"><span id="f4" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">컨센서스에 부합한 양호한 실적</span></div>
<div class="txt" style="position:absolute; left:49px; top:263px;"><span id="f4" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">4분기에는 일회성 자금유입으로 1조원의 현금을 보유하게 될 전망</span></div>
<div class="txt" style="position:absolute; left:49px; top:281px;"><span id="f4" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">31일 증선위 결과로 금융당국과의 불확실성 해소 기대</span></div>
<div class="txt" style="position:absolute; left:38px; top:324px;"><span id="f2" style="font-size:12px;vertical-align:baseline;color:rgba(85,146,206,1);">Facts : 컨센서스에 부합한 양호한 실적</span></div>
<div class="txt" style="position:absolute; left:38px; top:342px;"><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">3분기 영업이익은 105억원(-49% YoY, 영업이익률 10%)로 시장 컨센서스 102</span></div>
<div class="txt" style="position:absolute; left:38px; top:358px;"><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">억원에 부합했다. 1공장의 생산 스케줄에 따른 일시적 가동률 하락과 일부 인도시</span></div>
<div class="txt" style="position:absolute; left:38px; top:374px;"><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">점이 긴 제품의 매출인식이 4분기로 이연되면서 매출액은 전년 대비 21% 감소한</span></div>
<div class="txt" style="position:absolute; left:38px; top:390px;"><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">1,011억원을 기록했다. 가동률 하락 및 3공장에 대한 인건비 증가로 영업이익도</span></div>
<div class="txt" style="position:absolute; left:38px; top:406px;"><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">감소했다.</span></div>
<div class="txt" style="position:absolute; left:38px; top:436px;"><span id="f2" style="font-size:12px;vertical-align:baseline;color:rgba(85,146,206,1);">Pros &amp; cons : 4분기 일회성 자금유입으로 연간 순이익 흑자전환</span></div>
<div class="txt" style="position:absolute; left:38px; top:454px;"><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">Biogen으로부터의 콜옵션 대금(7,573억원) 유입이 4분기로 지연되고 지분법 손</span></div>
<div class="txt" style="position:absolute; left:38px; top:470px;"><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">실(-387억원)이 3분기에도 이어지면서 전분기에 이어 이번 분기에도 순손실</span></div>
<div class="txt" style="position:absolute; left:38px; top:486px;"><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">(301억원)을 시현했다는 점은 아쉽다. 그러나 4분기에는 콜옵션 대금과 Merck의</span></div>
<div class="txt" style="position:absolute; left:38px; top:502px;"><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">란투스 바이오시밀러 판매포기에 따른 투자원금 및 보상금(1,755억원)이 유입될</span></div>
<div class="txt" style="position:absolute; left:38px; top:518px;"><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">예정이다. 이에 따라 2018년 회사는 순이익은 3,542억원으로 흑자전환하고 약 1</span></div>
<div class="txt" style="position:absolute; left:38px; top:534px;"><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">조원의 현금을 보유하게 될 전망이다. 한편 회사는 신규사업의 일환으로</span></div>
<div class="txt" style="position:absolute; left:38px; top:550px;"><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">CDO(Contract Development Organization, 위탁개발) 사업에 대해 설명하는 자</span></div>
<div class="txt" style="position:absolute; left:38px; top:566px;"><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">리를 가졌다. 고객사와 신약 파이프라인 개발을 함께 하며 시판에 성공할 경우</span></div>
<div class="txt" style="position:absolute; left:38px; top:582px;"><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">CMO로 연계되는 사업모델을 추구하게 된다. 이미 지난 9월 미국</span></div>
<div class="txt" style="position:absolute; left:38px; top:598px;"><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">Immunomedics와 346억원 규모의 CDO 계약을 체결한 바 있으며 제품 개발 성</span></div>
<div class="txt" style="position:absolute; left:38px; top:614px;"><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">공시 2025년까지 계약금액이 1,845억원으로 증가할 수 있다. 신규 고객사 발굴</span></div>
<div class="txt" style="position:absolute; left:38px; top:630px;"><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">및 매출처 확대 차원에서 긍정적이다.</span></div>
<div class="txt" style="position:absolute; left:38px; top:660px;"><span id="f2" style="font-size:12px;vertical-align:baseline;color:rgba(85,146,206,1);">Action : 이제 남은 건 10월 31일 증선위 결과</span></div>
<div class="txt" style="position:absolute; left:38px; top:678px;"><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">한편 오는 31일 삼성바이오로직스의 회계부정 혐의에 대한 논의가 증선위 정례회</span></div>
<div class="txt" style="position:absolute; left:38px; top:694px;"><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">의에 상정됐다. 11월 중으로 예상되었던 금감원과 삼성바이오로직스의 2차 공방이</span></div>
<div class="txt" style="position:absolute; left:38px; top:710px;"><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">생각보다 빠르게 진행되면서 불확실성도 이달 말에는 해소될 전망이다. 내년에는</span></div>
<div class="txt" style="position:absolute; left:38px; top:726px;"><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">회계이슈에 대한 불확실성이 제거된 가운데 3공장 수주 본격화, 신규 바이오시밀</span></div>
<div class="txt" style="position:absolute; left:38px; top:742px;"><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">러 파이프라인 확대 등으로 긍정적 주가흐름을 기대한다. 삼성바이오로직스에 대</span></div>
<div class="txt" style="position:absolute; left:38px; top:758px;"><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">해 매수의견을 유지하며 DCF로 산출한 종전 목표주가 61만원을 유지한다.</span></div>
<div class="txt" style="position:absolute; left:412px; top:202px;"><span id="f3" style="font-size:18px;vertical-align:baseline;color:rgba(0,0,0,1);">매수(유지)</span></div>
<div class="txt" style="position:absolute; left:412px; top:234px;"><span id="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">목표주가: 610,000원(유지)</span></div>
<div class="txt" style="position:absolute; left:412px; top:259px;"><span id="f2" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">Stock Data</span></div>
<div class="txt" style="position:absolute; left:412px; top:271px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">KOSPI(10/23)</span></div>
<div class="txt" style="position:absolute; left:542px; top:271px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">2,106</span></div>
<div class="txt" style="position:absolute; left:412px; top:282px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">주가(10/23)</span></div>
<div class="txt" style="position:absolute; left:535px; top:282px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">417,500</span></div>
<div class="txt" style="position:absolute; left:412px; top:294px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">시가총액(십억원)</span></div>
<div class="txt" style="position:absolute; left:539px; top:294px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">27,624</span></div>
<div class="txt" style="position:absolute; left:412px; top:305px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">발행주식수(백만)</span></div>
<div class="txt" style="position:absolute; left:551px; top:305px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">66</span></div>
<div class="txt" style="position:absolute; left:412px; top:316px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">52주 최고/최저가(원)</span></div>
<div class="txt" style="position:absolute; left:511px; top:316px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">584,000/329,000</span></div>
<div class="txt" style="position:absolute; left:412px; top:328px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">일평균거래대금(6개월, 백만원)</span></div>
<div class="txt" style="position:absolute; left:535px; top:328px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">127,076</span></div>
<div class="txt" style="position:absolute; left:412px; top:339px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">유동주식비율/외국인지분율(%)</span></div>
<div class="txt" style="position:absolute; left:535px; top:339px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">24.6/9.3</span></div>
<div class="txt" style="position:absolute; left:412px; top:351px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">주요주주(%) 삼성물산 외 4 인</span></div>
<div class="txt" style="position:absolute; left:545px; top:351px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">75.1</span></div>
<div class="txt" style="position:absolute; left:412px; top:384px;"><span id="f2" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">Valuation 지표</span></div>
<div class="txt" style="position:absolute; left:412px; top:408px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">PER(x)</span></div>
<div class="txt" style="position:absolute; left:412px; top:419px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">PBR(x)</span></div>
<div class="txt" style="position:absolute; left:412px; top:430px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">ROE(%)</span></div>
<div class="txt" style="position:absolute; left:412px; top:442px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">DY(%)</span></div>
<div class="txt" style="position:absolute; left:412px; top:453px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">EV/EBITDA(x)</span></div>
<div class="txt" style="position:absolute; left:412px; top:465px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">EPS(원)</span></div>
<div class="txt" style="position:absolute; left:412px; top:476px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">BPS(원)</span></div>
<div class="txt" style="position:absolute; left:473px; top:397px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">2017A</span></div>
<div class="txt" style="position:absolute; left:480px; top:408px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">NM</span></div>
<div class="txt" style="position:absolute; left:481px; top:419px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">6.2</span></div>
<div class="txt" style="position:absolute; left:477px; top:430px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">(2.4)</span></div>
<div class="txt" style="position:absolute; left:481px; top:442px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">0.0</span></div>
<div class="txt" style="position:absolute; left:475px; top:453px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">181.8</span></div>
<div class="txt" style="position:absolute; left:470px; top:465px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">(1,466)</span></div>
<div class="txt" style="position:absolute; left:471px; top:476px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">60,099</span></div>
<div class="txt" style="position:absolute; left:506px; top:397px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">2018F</span></div>
<div class="txt" style="position:absolute; left:512px; top:408px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">78.0</span></div>
<div class="txt" style="position:absolute; left:515px; top:419px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">6.7</span></div>
<div class="txt" style="position:absolute; left:515px; top:430px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">8.7</span></div>
<div class="txt" style="position:absolute; left:515px; top:442px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">0.0</span></div>
<div class="txt" style="position:absolute; left:508px; top:453px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">187.8</span></div>
<div class="txt" style="position:absolute; left:508px; top:465px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">5,353</span></div>
<div class="txt" style="position:absolute; left:505px; top:476px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">62,395</span></div>
<div class="txt" style="position:absolute; left:540px; top:397px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">2019F</span></div>
<div class="txt" style="position:absolute; left:542px; top:408px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">185.3</span></div>
<div class="txt" style="position:absolute; left:549px; top:419px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">6.3</span></div>
<div class="txt" style="position:absolute; left:549px; top:430px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">3.5</span></div>
<div class="txt" style="position:absolute; left:549px; top:442px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">0.0</span></div>
<div class="txt" style="position:absolute; left:546px; top:453px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">83.8</span></div>
<div class="txt" style="position:absolute; left:542px; top:465px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">2,253</span></div>
<div class="txt" style="position:absolute; left:539px; top:476px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">66,680</span></div>
<div class="txt" style="position:absolute; left:412px; top:498px;"><span id="f2" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">주가상승률</span></div>
<div class="txt" style="position:absolute; left:412px; top:522px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">절대주가(%)</span></div>
<div class="txt" style="position:absolute; left:412px; top:533px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">KOSPI 대비(%p)</span></div>
<div class="txt" style="position:absolute; left:485px; top:511px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">1개월</span></div>
<div class="txt" style="position:absolute; left:483px; top:522px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">(21.2)</span></div>
<div class="txt" style="position:absolute; left:483px; top:533px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">(11.3)</span></div>
<div class="txt" style="position:absolute; left:514px; top:511px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">6개월</span></div>
<div class="txt" style="position:absolute; left:512px; top:522px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">(11.7)</span></div>
<div class="txt" style="position:absolute; left:520px; top:533px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">3.1</span></div>
<div class="txt" style="position:absolute; left:539px; top:511px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">12개월</span></div>
<div class="txt" style="position:absolute; left:546px; top:522px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">10.3</span></div>
<div class="txt" style="position:absolute; left:546px; top:533px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">25.7</span></div>
<div class="txt" style="position:absolute; left:412px; top:555px;"><span id="f2" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">주가추이</span></div>
<div class="txt" style="position:absolute; left:430px; top:573px;"><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(천원)</span></div>
<div class="txt" style="position:absolute; left:414px; top:578px;"><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">600</span></div>
<div class="txt" style="position:absolute; left:414px; top:593px;"><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">500</span></div>
<div class="txt" style="position:absolute; left:414px; top:608px;"><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">400</span></div>
<div class="txt" style="position:absolute; left:414px; top:622px;"><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">300</span></div>
<div class="txt" style="position:absolute; left:414px; top:637px;"><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">200</span></div>
<div class="txt" style="position:absolute; left:414px; top:652px;"><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">100</span></div>
<div class="txt" style="position:absolute; left:424px; top:659px;"><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Oct-16</span></div>
<div class="txt" style="position:absolute; left:412px; top:674px;"><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">자료: WISEfn</span></div>
<div class="txt" style="position:absolute; left:478px; top:659px;"><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Oct-17</span></div>
<div class="txt" style="position:absolute; left:532px; top:659px;"><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Oct-18</span></div>
<div class="txt" style="position:absolute; left:412px; top:707px;"><span id="f2" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">진홍국</span></div>
<div class="txt" style="position:absolute; left:412px; top:724px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">hg.jin@truefriend.com</span></div>
<div class="txt" style="position:absolute; left:412px; top:741px;"><span id="f2" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">정은영</span></div>
<div class="txt" style="position:absolute; left:412px; top:758px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">eunice.jung@truefriend.com</span></div>
</body>
</html>
